The European Society for Blood and Marrow Transplantation (EBMT) has released its ninth special report on indications for hematopoietic cell transplantation (HCT) and chimeric antigen receptor T-cell (CAR-T) therapy. The report provides updated guidance for clinicians treating hematological diseases, solid tumors, and immune disorders.
This article was originally published on MedicalXpress.com